Out of 12 patients with CNS tumors, positive results (Tier IA/IB) were found in 2 patients (1 men, 1 women), one of which had mutations in the IDH1 gene and the other in the NF1 gene. This evidence concerns the gene NF1 and central nervous system neoplasm.